The Effect of Suboccipital Release Technique in Individuals With Anxiety

NCT05811052 | Completed

• 1 other identifier: AIBU-FTR-ST-02
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to determine the immediate effect of the suboccipital release technique on trapezius muscle pain threshold, muscle activation, and anxiety level in individuals with anxiety.Thirty-six people with anxiety symptoms were included in the study. These people were divided into two groups, 18 control group and 18 treatment group. Upper trapezius muscle pain threshold, muscle activation and anxiety levels were evaluated. The experimental group received a single session of suboccipital release technique. The control group received a single session of sham suboccipital release. The evaluations were performed before and immediately after the treatment.The suboccipital release technique can increase the trapezius muscle upper part pain threshold and concentric muscle activation immediately after the application in individuals with anxiety.

Conditions

Anxiety; Trapezius Muscle Strain; Pain

Outcome Measures

Primary Outcomes (4)

• The State- Trait Anxiety Inventory

  The State Anxiety Scale includes questions that require the respondent to answer by taking into account his/her current feelings, while the Trait Anxiety Scale includes questions that evaluate how the respondent feels in general. It is a 4-point Likert scale. The total score obtained from both scales is minimum 20 and maximum 80. A high score indicates a high level of anxiety and a low score indicates a low level of anxiety.

  Change from Baseline Anxiety Level at immediately after treatment

• Pain Assessment

  Pain threshold was evaluated with a manual algometer device. The midpoint of the upper trapezius muscle and the tender point with the highest pain were marked.

  Change from Baseline anxiety level at Immediately After treatment

• Surface Electromyography Measurements

  Maximum Voluntary Concentration (MVC) value was then measured. For the MVC value, individuals were asked to push their shoulders up (in the upward direction) against a manual resistance for 5 seconds. The measurement was repeated 3 times and 2 rests were taken after each measurement. The highest of the values was used for normalization. Afterwards, the subjects were asked to perform active shoulder elevation (concentric activity) for 3 seconds and return to neutral position for 3 seconds with the metronome. For normalization, % MVC and function % MVC values were calculated using the values recorded for all recordings.

  Change from Baseline anxiety level at Immediately After treatment

• Hospital Anxiety and Depression Scale

  Toplam 14 maddeden oluşan (/ Anksiyete ve 7 Depresyon sorusu). 4'lü Likert tipinde bir ölçektir. 0-3 arasında bir puanlama yapılırç 0-1 puan hasta olmayan, 2 puan sınırda hasta, 2-3 puan ağır hasta olarak değerlendirilir.

  Baseline

Secondary Outcomes (1)

• Cranial Rhythm

  Change from Baseline anxiety level at Immediately After treatment

Study Arms (2)

Suboccipital Release Group

EXPERIMENTAL

Other: Suboccipital Release Technique

Control Group

SHAM COMPARATOR

Other: Sham Suboccipital Release

Interventions

Suboccipital Release Technique OTHER

The suboccipital release technique was applied to the participants in the experimental group by an experienced practitioner who had received osteopathy training. The individual lay in the supine position, and the practitioner applied the relaxation technique by placing his hands on the patient's nape-atlantooccipital joint. The application was continued until the relaxation of the muscles under the hand of the practitioner.

Suboccipital Release Group

Sham Suboccipital Release OTHER

The participants in the control group were given a sham application by touching the hands of the therapist on the nape of the neck and waiting for a while.

Control Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being over the age of 18
• Agree to participate the study

You may not qualify if:

• Use psychiatric, analgesic and antispasmodic drugs

Sponsors & Collaborators

• Abant Izzet Baysal University: lead

Study Sites (1)

sezen Tezcan

Bolu, Merkez, 14200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders; Pain

Condition Hierarchy (Ancestors)

Mental Disorders; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assist. Prof

Study Record Dates

• First Submitted: March 20, 2023
• First Posted: April 13, 2023
• Study Start: March 1, 2022
• Primary Completion: July 6, 2022
• Study Completion: February 28, 2023
• Last Updated: May 13, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)